首页 > 最新文献

中华实验外科杂志最新文献

英文 中文
Structural design of femoral stem trabecular bone and biomechanical simulation analysis 股骨干小梁骨结构设计及生物力学仿真分析
Pub Date : 2020-01-08 DOI: 10.3760/CMA.J.ISSN.1001-9030.2020.01.020
Xing Wang, Ying Wu, X. Gong, Z. Qiao, Zhaoli Wu, Hongquan Lei, Zhi-Ping Guo, W. Luo
{"title":"Structural design of femoral stem trabecular bone and biomechanical simulation analysis","authors":"Xing Wang, Ying Wu, X. Gong, Z. Qiao, Zhaoli Wu, Hongquan Lei, Zhi-Ping Guo, W. Luo","doi":"10.3760/CMA.J.ISSN.1001-9030.2020.01.020","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1001-9030.2020.01.020","url":null,"abstract":"","PeriodicalId":10065,"journal":{"name":"中华实验外科杂志","volume":"37 1","pages":"70-70"},"PeriodicalIF":0.0,"publicationDate":"2020-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47909413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MicroRNA-224 mediates lipopolysaccharide-induced injury of pulmonary microvascular endothelium cells via regulating p21 MicroRNA-224通过调节p21介导脂多糖诱导的肺微血管内皮细胞损伤
Pub Date : 2020-01-08 DOI: 10.3760/CMA.J.ISSN.1001-9030.2020.01.023
Jun Hong, Jingquan Liu, Fangxiao Gong, Lingzhi Jiang, Shijing Mo, Minhua Chen, Xianghong Yang, R. Sun
Objective To investigate the effects of microRNA (miRNA, miR)-224 level changes on the lipopolysaccharide (LPS)-induced injury of pulmonary microvascular endothelium cells (PMVECs) and its mechanism. Methods Primary PMVECs were isolated from clean-level BALB/c mice and cultured in vitro. In order to induce cells injury, 1.0 mg/L LPS was used to treat PMVECs. MiR-224 inhibitor and p21 siRNA were transfected for silencing miR-224 and p21, respectively. The cell viability and apoptosis rate of PMVECs were detected by cell counting kit-8 reagent and flow cytometry, respectively. The changes of miR-224 and p21 were detected by fluorescent quantitative polymerase chain reaction (FQ-PCR) and Western blotting. Dual-luciferase reporter assay was used to determine the target relationship between miR-224 and p21. T-test was used to compare the mean between the two groups and the pairwise comparison of the mean among multiple groups was conducted by LSD test on the basis of one-way analysis of variance. Results After LPS treatment, the relative cell viability decreased to (42.333±7.586)% and apoptosis rate increased to (32.141±2.449)% as compared with non-LPS treated cells. Meanwhile, the level of miR-224 increased to 1.791±0.167 with a decreased p21 mRNA expression (0.527±0.058) (t=8.532, 7.261, 7.113 and 8.467, P<0.01). As compared with simple LPS treated cells, PMVECs transfected with miR-224 inhibitor showed lower cell inhibition and apoptosis rate after LPS treatment (F=62.618 and 32.643, P<0.01). However, p21 knock-down could antagonize the protective effect of miR-224. Conclusion MiR-224 may mediate the LPS-induced injury of PMVECs via targeting p21. MiR-224 could be a therapy target for acute lung injury/acute respiratory distress syndrome after sepsis. Key words: Sepsis; Lipopolysaccharide; Endotheliumcell; Acute lung injury; Acute respiratory distress syndrome; MicroRNA; P21
目的探讨microRNA (miRNA, miR)-224水平变化对脂多糖(LPS)诱导的肺微血管内皮细胞(PMVECs)损伤的影响及其机制。方法从清洁水平的BALB/c小鼠中分离原代pmvec并进行体外培养。为了诱导细胞损伤,用1.0 mg/L LPS处理pmvec。转染MiR-224 inhibitor和p21 siRNA,分别沉默MiR-224和p21。分别用细胞计数试剂盒-8试剂盒和流式细胞术检测PMVECs的细胞活力和凋亡率。采用荧光定量聚合酶链反应(FQ-PCR)和Western blotting检测miR-224和p21的变化。采用双荧光素酶报告基因法确定miR-224与p21之间的靶标关系。两组均数比较采用t检验,多组均数两两比较采用单因素方差分析基础上的LSD检验。结果与非LPS处理的细胞相比,LPS处理后的细胞相对活力下降至(42.333±7.586)%,细胞凋亡率上升至(32.141±2.449)%。miR-224水平升高至1.791±0.167,p21 mRNA表达降低(0.527±0.058)(t=8.532、7.261、7.113、8.467,P<0.01)。与单纯LPS处理的细胞相比,转染miR-224 inhibitor的PMVECs在LPS处理后的细胞抑制率和凋亡率均较低(F=62.618和32.643,P<0.01)。然而,p21敲除可拮抗miR-224的保护作用。结论MiR-224可能通过靶向p21介导lps诱导的PMVECs损伤。MiR-224可能成为脓毒症后急性肺损伤/急性呼吸窘迫综合征的治疗靶点。关键词:脓毒症;脂多糖;Endotheliumcell;急性肺损伤;急性呼吸窘迫综合征;微rna;P21
{"title":"MicroRNA-224 mediates lipopolysaccharide-induced injury of pulmonary microvascular endothelium cells via regulating p21","authors":"Jun Hong, Jingquan Liu, Fangxiao Gong, Lingzhi Jiang, Shijing Mo, Minhua Chen, Xianghong Yang, R. Sun","doi":"10.3760/CMA.J.ISSN.1001-9030.2020.01.023","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1001-9030.2020.01.023","url":null,"abstract":"Objective \u0000To investigate the effects of microRNA (miRNA, miR)-224 level changes on the lipopolysaccharide (LPS)-induced injury of pulmonary microvascular endothelium cells (PMVECs) and its mechanism. \u0000 \u0000 \u0000Methods \u0000Primary PMVECs were isolated from clean-level BALB/c mice and cultured in vitro. In order to induce cells injury, 1.0 mg/L LPS was used to treat PMVECs. MiR-224 inhibitor and p21 siRNA were transfected for silencing miR-224 and p21, respectively. The cell viability and apoptosis rate of PMVECs were detected by cell counting kit-8 reagent and flow cytometry, respectively. The changes of miR-224 and p21 were detected by fluorescent quantitative polymerase chain reaction (FQ-PCR) and Western blotting. Dual-luciferase reporter assay was used to determine the target relationship between miR-224 and p21. T-test was used to compare the mean between the two groups and the pairwise comparison of the mean among multiple groups was conducted by LSD test on the basis of one-way analysis of variance. \u0000 \u0000 \u0000Results \u0000After LPS treatment, the relative cell viability decreased to (42.333±7.586)% and apoptosis rate increased to (32.141±2.449)% as compared with non-LPS treated cells. Meanwhile, the level of miR-224 increased to 1.791±0.167 with a decreased p21 mRNA expression (0.527±0.058) (t=8.532, 7.261, 7.113 and 8.467, P<0.01). As compared with simple LPS treated cells, PMVECs transfected with miR-224 inhibitor showed lower cell inhibition and apoptosis rate after LPS treatment (F=62.618 and 32.643, P<0.01). However, p21 knock-down could antagonize the protective effect of miR-224. \u0000 \u0000 \u0000Conclusion \u0000MiR-224 may mediate the LPS-induced injury of PMVECs via targeting p21. MiR-224 could be a therapy target for acute lung injury/acute respiratory distress syndrome after sepsis. \u0000 \u0000 \u0000Key words: \u0000Sepsis; Lipopolysaccharide; Endotheliumcell; Acute lung injury; Acute respiratory distress syndrome; MicroRNA; P21","PeriodicalId":10065,"journal":{"name":"中华实验外科杂志","volume":"37 1","pages":"81-83"},"PeriodicalIF":0.0,"publicationDate":"2020-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41896948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishment of mouse atherosclerotic model 小鼠动脉粥样硬化模型的建立
Pub Date : 2020-01-08 DOI: 10.3760/CMA.J.ISSN.1001-9030.2020.01.050
Yiquan Dai, Xiaoxiao Yan, Xiao‐Ru Liu, Yichen Lin, Hongyu Chen
Objective To establish a stable and reliable mouse atherosclerotic (AS) model, and standardize principal process of AS model identification. Methods The mouse AS model was developed by feeding apolipoprotein E (ApoE) gene knockout mice (ApoE-/-) on high-fat diet (hfd). Sixteen weeks later, the body weight, blood sugar, blood pressure and blood lipid were determined, and aortas were stained with oil red O and hematoxylin to evaluate the AS plaque. Results Cholesterol [(20.09±1.02) mmol/L] and low density lipoprotein cholesterol [(6.84±0.65) mmol/L] of ApoE-/- mice with hfd were significantly increased as compared with that in C57BL/6J normal diet (nd) group [total cholesterol (TC): (2.04±0.07) mmol/L, LDL-C: (0.25±0.01) mmol/L, F=190.543, 82.795, P<0.01]. Oil Red O staining of entire aorta showed that AS lesion size in ApoE-/-+ hfd mice [(22.09±3.49)%] was dramatically increased as compared with that in ApoE-/-+ nd mice [(1.46±0.96)%, F=118.558, P<0.01]. Similar result was obtained from cross-sections of aortic root analysis. Hematoxylin and eosin (HE) staining of cross-sections of aorta root showed typical As plaques. Conclusion The hfd treatment successfully promoted AS development in ApoE-/- mice. The process of gene identification-general situation analysis-blood lipid analysis-morphologic analysis was established to verify AS model. The establishment of mouse AS model provides a valuable tool for the study of AS-related diseases in vivo. Key words: Atherosclerosis; Gene knock out mice; Low density lipoprotein; Cholesterol; Lorta
目的建立稳定可靠的小鼠动脉粥样硬化(AS)模型,规范AS模型鉴定的主要过程。方法采用高脂饲料(hfd)喂养载脂蛋白E (ApoE)基因敲除小鼠(ApoE-/-)建立小鼠AS模型。16周后测定体重、血糖、血压、血脂,并对主动脉进行油红O和苏木精染色,评价AS斑块。结果与C57BL/6J正常饮食(和)组相比,ApoE-/- hfd小鼠的胆固醇[(20.09±1.02)mmol/L]和低密度脂蛋白胆固醇[(6.84±0.65)mmol/L]显著升高[总胆固醇(TC):(2.04±0.07)mmol/L, LDL-C:(0.25±0.01)mmol/L, F=190.543, 82.795, P<0.01]。全主动脉油红O染色显示,ApoE-/-+ hfd小鼠AS病变大小[(22.09±3.49)%]较ApoE-/-+小鼠[(1.46±0.96)%,F=118.558, P<0.01]显著增加。主动脉根部横切面分析也得到了类似的结果。苏木精和伊红(HE)染色显示主动脉根横断面典型的As斑块。结论hfd有效促进了ApoE-/-小鼠AS的发展。建立基因鉴定-概况分析-血脂分析-形态学分析的流程对AS模型进行验证。小鼠AS模型的建立为体内AS相关疾病的研究提供了有价值的工具。关键词:动脉粥样硬化;基因敲除小鼠;低密度脂蛋白;胆固醇;Lorta
{"title":"Establishment of mouse atherosclerotic model","authors":"Yiquan Dai, Xiaoxiao Yan, Xiao‐Ru Liu, Yichen Lin, Hongyu Chen","doi":"10.3760/CMA.J.ISSN.1001-9030.2020.01.050","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1001-9030.2020.01.050","url":null,"abstract":"Objective \u0000To establish a stable and reliable mouse atherosclerotic (AS) model, and standardize principal process of AS model identification. \u0000 \u0000 \u0000Methods \u0000The mouse AS model was developed by feeding apolipoprotein E (ApoE) gene knockout mice (ApoE-/-) on high-fat diet (hfd). Sixteen weeks later, the body weight, blood sugar, blood pressure and blood lipid were determined, and aortas were stained with oil red O and hematoxylin to evaluate the AS plaque. \u0000 \u0000 \u0000Results \u0000Cholesterol [(20.09±1.02) mmol/L] and low density lipoprotein cholesterol [(6.84±0.65) mmol/L] of ApoE-/- mice with hfd were significantly increased as compared with that in C57BL/6J normal diet (nd) group [total cholesterol (TC): (2.04±0.07) mmol/L, LDL-C: (0.25±0.01) mmol/L, F=190.543, 82.795, P<0.01]. Oil Red O staining of entire aorta showed that AS lesion size in ApoE-/-+ hfd mice [(22.09±3.49)%] was dramatically increased as compared with that in ApoE-/-+ nd mice [(1.46±0.96)%, F=118.558, P<0.01]. Similar result was obtained from cross-sections of aortic root analysis. Hematoxylin and eosin (HE) staining of cross-sections of aorta root showed typical As plaques. \u0000 \u0000 \u0000Conclusion \u0000The hfd treatment successfully promoted AS development in ApoE-/- mice. The process of gene identification-general situation analysis-blood lipid analysis-morphologic analysis was established to verify AS model. The establishment of mouse AS model provides a valuable tool for the study of AS-related diseases in vivo. \u0000 \u0000 \u0000Key words: \u0000Atherosclerosis; Gene knock out mice; Low density lipoprotein; Cholesterol; Lorta","PeriodicalId":10065,"journal":{"name":"中华实验外科杂志","volume":"37 1","pages":"172-175"},"PeriodicalIF":0.0,"publicationDate":"2020-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44866914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of neural stem cells in combination with nerve neurotrophic factor 3 gene modified olfactory ensheathing cell co-transplants on functional recovery after traumatic brain injury in the adult rats 神经干细胞联合神经营养因子3基因修饰嗅鞘细胞共移植对成年大鼠创伤性脑损伤后功能恢复的影响
Pub Date : 2020-01-08 DOI: 10.3760/CMA.J.ISSN.1001-9030.2020.01.021
Yaozong Yan, B. Jin, Xin-zhong Zhang, Haiming Li, Wenke Zhou, Dainan Zhang
Objective To observe the effects of neural stem cells (NSCs) combined with neurotrophin-3 gene modified olfactory ensheathing cells (OECs-NT-3) co-transplants on functional recovery after traumatic brain injury in the adult rats. Methods NSCs and OECs were cultured from hippocampus and olfactory bulb of neonatal rats and then identified. OECs-NT-3 was constructed by lentiviral vector containing NT-3 gene. Male SD rats weighing (200±20) g were randomly divided into sham group, model group, OECs-NT-3 transplantation group, NSCs transplantation group and OECs-NT-3 combined NSCs transplantation group. The rat brain injury model was established. The corresponding cells were transplanted. At day 1, 7, 14 and 28 after transplantation, the modified neurological severity score (mNSS) was used to evaluate neurological function, and brain tissues were taken at each time point for paraffin sections. Hematoxylin-eosin staining was performed. Cell apoptosis was detected by terminal-deoxynucleotidyl transferase mediated nick end labeling (TUNEL) method. Immunohistochemical staining of BrdU and p75 was done. Results At day 28 of transplantation, the mNSS scores in rats in the combined group (4.00±1.05) were significantly different from those in the model group (8.50±1.43), the OECs-NT-3 group (5.50±1.35) and the NSCs group (6.00±1.49) (t=-7.997, -2.764, -3.464, P 0.05). Hematoxylin and eosin (HE) staining revealed that the cell density in the sham group, model group, OECs-NT-3 group, NSCs group and the combined group was (220±22), (299±47), (347±35), (390±72) and (523±55) cells, respectively. As compared with the model group, OECs-NT-3 group and NSCs group, the cell density in the combined group was significantly increased (t=7.246, 5.996, 3.373, P<0.05), and the tissue structure was relatively regular. The p75 and BrdU immunohistochemistry showed that the two kinds of transplanted cells could survive continuously and were widely distributed around the lesion. At day 7 after transplantation, the apoptotic index in the sham group, model group, OECs-NT-3 group, NSCs group and combined group was (1.67±0.17)%, (47.49±7.92)%, (31.22±3.97)%, (34.48±4.69)% and (18.17±3.13)% respectively. The apoptosis rate in the combined transplantation group was significantly lower than that in the model group, OECs-NT-3 group and NSCs group (t=5.963, 4.470, 5.012, P<0.05). Conclusion Transplantation of NSCs combined with OECs-NT-3 can alleviate neuronal apoptosis after brain injury in rats, repair tissue defects, and promote the recovery of nerve function. Key words: Neural stem cell; Neurotrophin-3 gene; Gene modify; Olfactory ensheathing cells; Combined transplantation; Traumatic brain injury
目的观察神经干细胞(NSCs)与神经营养因子-3基因修饰的嗅鞘细胞(OECs-NT-3)联合移植对成年大鼠颅脑损伤后功能恢复的影响。方法从新生大鼠海马和嗅球培养NSCs和OECs,并进行鉴定。利用含有NT-3基因的慢病毒载体构建OECs-NT-3。雄性SD大鼠体重(200±20)g,随机分为假手术组、模型组、OECs-NT-3移植组、NSCs移植组和OECs-NPT-3联合NSCs移植对照组。建立大鼠脑损伤模型。相应的细胞被移植。在移植后第1、7、14和28天,使用改良的神经严重程度评分(mNSS)来评估神经功能,并在每个时间点取脑组织进行石蜡切片。苏木精-伊红染色。用末端脱氧核苷酸转移酶介导的缺口末端标记法(TUNEL)检测细胞凋亡。对BrdU和p75进行免疫组织化学染色。结果移植第28天,联合组大鼠mNSS评分(4.00±1.05)与模型组(8.50±1.43)、OECs-NT-3组(5.50±1.35)和NSCs组(6.00±1.49)有显著差异(t=-7.997、-2.764、-3.464,P 0.05),NSCs组和联合组分别为(220±22)、(299±47)、(347±35)、(390±72)和(523±55)个细胞。与模型组、OECs-NT-3组和NSCs组相比,联合组的细胞密度显著增加(t=7.246,5.996,3.373,P<0.05),组织结构相对规则。p75和BrdU免疫组化显示,两种移植细胞均能连续存活,并广泛分布于病变周围。移植后第7天,假手术组、模型组、OECs-NT-3组、NSCs组和联合用药组的细胞凋亡指数分别为(1.67±0.17)%、(47.49±7.92)%、“31.22±3.97”%、“34.48±4.69”%和“18.17±3.13”%。联合移植组的细胞凋亡率明显低于模型组、OECs-NT-3组和NSCs组(t=5.963,4.470,5.012,P<0.05)。关键词:神经干细胞;神经营养素-3基因;基因修饰;嗅鞘细胞;联合移植;创伤性脑损伤
{"title":"Effects of neural stem cells in combination with nerve neurotrophic factor 3 gene modified olfactory ensheathing cell co-transplants on functional recovery after traumatic brain injury in the adult rats","authors":"Yaozong Yan, B. Jin, Xin-zhong Zhang, Haiming Li, Wenke Zhou, Dainan Zhang","doi":"10.3760/CMA.J.ISSN.1001-9030.2020.01.021","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1001-9030.2020.01.021","url":null,"abstract":"Objective \u0000To observe the effects of neural stem cells (NSCs) combined with neurotrophin-3 gene modified olfactory ensheathing cells (OECs-NT-3) co-transplants on functional recovery after traumatic brain injury in the adult rats. \u0000 \u0000 \u0000Methods \u0000NSCs and OECs were cultured from hippocampus and olfactory bulb of neonatal rats and then identified. OECs-NT-3 was constructed by lentiviral vector containing NT-3 gene. Male SD rats weighing (200±20) g were randomly divided into sham group, model group, OECs-NT-3 transplantation group, NSCs transplantation group and OECs-NT-3 combined NSCs transplantation group. The rat brain injury model was established. The corresponding cells were transplanted. At day 1, 7, 14 and 28 after transplantation, the modified neurological severity score (mNSS) was used to evaluate neurological function, and brain tissues were taken at each time point for paraffin sections. Hematoxylin-eosin staining was performed. Cell apoptosis was detected by terminal-deoxynucleotidyl transferase mediated nick end labeling (TUNEL) method. Immunohistochemical staining of BrdU and p75 was done. \u0000 \u0000 \u0000Results \u0000At day 28 of transplantation, the mNSS scores in rats in the combined group (4.00±1.05) were significantly different from those in the model group (8.50±1.43), the OECs-NT-3 group (5.50±1.35) and the NSCs group (6.00±1.49) (t=-7.997, -2.764, -3.464, P 0.05). Hematoxylin and eosin (HE) staining revealed that the cell density in the sham group, model group, OECs-NT-3 group, NSCs group and the combined group was (220±22), (299±47), (347±35), (390±72) and (523±55) cells, respectively. As compared with the model group, OECs-NT-3 group and NSCs group, the cell density in the combined group was significantly increased (t=7.246, 5.996, 3.373, P<0.05), and the tissue structure was relatively regular. The p75 and BrdU immunohistochemistry showed that the two kinds of transplanted cells could survive continuously and were widely distributed around the lesion. At day 7 after transplantation, the apoptotic index in the sham group, model group, OECs-NT-3 group, NSCs group and combined group was (1.67±0.17)%, (47.49±7.92)%, (31.22±3.97)%, (34.48±4.69)% and (18.17±3.13)% respectively. The apoptosis rate in the combined transplantation group was significantly lower than that in the model group, OECs-NT-3 group and NSCs group (t=5.963, 4.470, 5.012, P<0.05). \u0000 \u0000 \u0000Conclusion \u0000Transplantation of NSCs combined with OECs-NT-3 can alleviate neuronal apoptosis after brain injury in rats, repair tissue defects, and promote the recovery of nerve function. \u0000 \u0000 \u0000Key words: \u0000Neural stem cell; Neurotrophin-3 gene; Gene modify; Olfactory ensheathing cells; Combined transplantation; Traumatic brain injury","PeriodicalId":10065,"journal":{"name":"中华实验外科杂志","volume":"37 1","pages":"71-74"},"PeriodicalIF":0.0,"publicationDate":"2020-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47615585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between mitochondrial succinate dehydrogenase gene mutation and clinicopathological features of carotid body tumor and its predictive value for prognosis 线粒体琥珀酸脱氢酶基因突变与颈动脉体瘤临床病理特征的关系及其对预后的预测价值
Pub Date : 2020-01-08 DOI: 10.3760/CMA.J.ISSN.1001-9030.2020.01.036
Z. Hua, Gaopo Cai, Linfeng Zhang, Shirui Liu, Y. Yue, Zhen Li
Objective To analyze the correlation between mitochondrial succinate dehydrogenase (SDH) subunit (A, B, C, D) gene mutations and clinicopathological features of carotid body tumor (CBT) and to explore its prognostic value. Methods Ninety-five patients with sporadic CBT (CBT group) (male 43/female 52), aged 39-70 years old, were all unilateral tumors (55 left/40 right), with tumor diameter of 1.5-10.0 cm. Glenner’s classification was as follows: chemoreceptor tumor in 47 cases, pheochromocytoma in 44 cases, mixed type in 4 cases. The 95 healthy subjects (male 41/female 54), aged 10-69, were selected as the healthy group. PCR was used to amplify the exons of each sub unit gene of SDH and determine the DNA sequence. The gene mutation rate of each sub unit of SDH in CBT group and healthy group was compared. The relationship between the subunits with different mutation rate and the clinicopathological characteristics of the patients and the influence on the prognosis and survival were analyzed, and its predictive value to prognosis was analyzed by logistic regression analysis, and the survival rate of Kaplan Meier was analyzed. Results The mutation rate of SDHB and sDHD in CBT group was 26.32% and 8.84%, respectively. There were no significant differences in the mutation rate of SDHA, SDHC and SDHD between the CBT group and the healthy group (χ2=2.021, 2.212, P>0.05). The mutation rate of SDHB in the CBT group was significantly higher than that in the healthy group (χ2=18.472, P 0.05). The proportion of capsule incompleteness, infiltration of adjacent soft tissue and lymph node metastasis in SDHB mutation group was significantly higher than that in SDHB mutation group (χ2/Z=4.859, 5.566, 9.365, P<0.05). Logistic regression analysis showed that age over 60 years old, incomplete capsule, infiltration of adjacent soft tissue, lymph node metastasis and SDHB mutation were all risk factors for poor prognosis of CBT patients [odds ratio (OR)=2.264, 3.596, 3.117, 3.320, 2.440, P<0.05]. The median follow-up time of 95 patients was 42 months. The 3-year disease-free survival rate of the patients in the non-mutation group and the mutation group was 95.71% and 64.00%, respectively, and the analysis of survival curve showed that the 3-year disease-free survival rate of patients in the non-mutation group of SDHB was significantly higher than that in the mutation group of SDHB (χ2=7.309, P<0.05). Conclusion CBT patients are easy to carry SDHB and SDHD mutation genes. The SDHB mutation gene is closely related to CBT differentiation degree, presence or absence of distant metastasis and prognosis. Key words: Carotid body tumor; Mitochondrial succinate dehydrogenase; Gene mutation; Pathological features; Prognosis
目的分析线粒体琥珀酸脱氢酶(SDH)亚基(A、B、C、D)基因突变与颈动脉体瘤(CBT)临床病理特征的相关性,探讨其预后价值。方法散发性CBT患者95例(CBT组),男43例/女52例,年龄39 ~ 70岁,均为单侧肿瘤(左55例/右40例),肿瘤直径1.5 ~ 10.0 cm。Glenner分类:化学受体肿瘤47例,嗜铬细胞瘤44例,混合型4例。健康组95例,男41例,女54例,年龄10 ~ 69岁。采用PCR扩增SDH各亚基基因外显子,确定DNA序列。比较CBT组与健康组SDH各亚单位基因突变率。分析不同突变率亚基与患者临床病理特征的关系及对预后和生存的影响,采用logistic回归分析其对预后的预测价值,并分析Kaplan Meier生存率。结果CBT组SDHB和sDHD的突变率分别为26.32%和8.84%。CBT组与健康组SDHA、SDHC、SDHD的突变率比较,差异均无统计学意义(χ2=2.021, 2.212, P < 0.05)。CBT组SDHB突变率显著高于健康组(χ2=18.472, p0.05)。SDHB突变组包膜不完整、邻近软组织浸润、淋巴结转移比例显著高于SDHB突变组(χ2/Z=4.859、5.566、9.365,P<0.05)。Logistic回归分析显示,年龄大于60岁、包膜不全、邻近软组织浸润、淋巴结转移、SDHB突变均为CBT患者预后不良的危险因素[比值比(OR)=2.264、3.596、3.117、3.320、2.440,P<0.05]。95例患者中位随访时间为42个月。非突变组和突变组患者3年无病生存率分别为95.71%和64.00%,生存曲线分析显示,SDHB非突变组患者3年无病生存率显著高于SDHB突变组(χ2=7.309, P<0.05)。结论CBT患者易携带SDHB及SDHD突变基因。SDHB突变基因与CBT分化程度、有无远处转移及预后密切相关。关键词:颈动脉体瘤;线粒体琥珀酸脱氢酶;基因突变;病理特征;预后
{"title":"Relationship between mitochondrial succinate dehydrogenase gene mutation and clinicopathological features of carotid body tumor and its predictive value for prognosis","authors":"Z. Hua, Gaopo Cai, Linfeng Zhang, Shirui Liu, Y. Yue, Zhen Li","doi":"10.3760/CMA.J.ISSN.1001-9030.2020.01.036","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1001-9030.2020.01.036","url":null,"abstract":"Objective \u0000To analyze the correlation between mitochondrial succinate dehydrogenase (SDH) subunit (A, B, C, D) gene mutations and clinicopathological features of carotid body tumor (CBT) and to explore its prognostic value. \u0000 \u0000 \u0000Methods \u0000Ninety-five patients with sporadic CBT (CBT group) (male 43/female 52), aged 39-70 years old, were all unilateral tumors (55 left/40 right), with tumor diameter of 1.5-10.0 cm. Glenner’s classification was as follows: chemoreceptor tumor in 47 cases, pheochromocytoma in 44 cases, mixed type in 4 cases. The 95 healthy subjects (male 41/female 54), aged 10-69, were selected as the healthy group. PCR was used to amplify the exons of each sub unit gene of SDH and determine the DNA sequence. The gene mutation rate of each sub unit of SDH in CBT group and healthy group was compared. The relationship between the subunits with different mutation rate and the clinicopathological characteristics of the patients and the influence on the prognosis and survival were analyzed, and its predictive value to prognosis was analyzed by logistic regression analysis, and the survival rate of Kaplan Meier was analyzed. \u0000 \u0000 \u0000Results \u0000The mutation rate of SDHB and sDHD in CBT group was 26.32% and 8.84%, respectively. There were no significant differences in the mutation rate of SDHA, SDHC and SDHD between the CBT group and the healthy group (χ2=2.021, 2.212, P>0.05). The mutation rate of SDHB in the CBT group was significantly higher than that in the healthy group (χ2=18.472, P 0.05). The proportion of capsule incompleteness, infiltration of adjacent soft tissue and lymph node metastasis in SDHB mutation group was significantly higher than that in SDHB mutation group (χ2/Z=4.859, 5.566, 9.365, P<0.05). Logistic regression analysis showed that age over 60 years old, incomplete capsule, infiltration of adjacent soft tissue, lymph node metastasis and SDHB mutation were all risk factors for poor prognosis of CBT patients [odds ratio (OR)=2.264, 3.596, 3.117, 3.320, 2.440, P<0.05]. The median follow-up time of 95 patients was 42 months. The 3-year disease-free survival rate of the patients in the non-mutation group and the mutation group was 95.71% and 64.00%, respectively, and the analysis of survival curve showed that the 3-year disease-free survival rate of patients in the non-mutation group of SDHB was significantly higher than that in the mutation group of SDHB (χ2=7.309, P<0.05). \u0000 \u0000 \u0000Conclusion \u0000CBT patients are easy to carry SDHB and SDHD mutation genes. The SDHB mutation gene is closely related to CBT differentiation degree, presence or absence of distant metastasis and prognosis. \u0000 \u0000 \u0000Key words: \u0000Carotid body tumor; Mitochondrial succinate dehydrogenase; Gene mutation; Pathological features; Prognosis","PeriodicalId":10065,"journal":{"name":"中华实验外科杂志","volume":"37 1","pages":"124-127"},"PeriodicalIF":0.0,"publicationDate":"2020-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44454926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression and clinical significance of circulating microRNA-375 and tissue Yes-associated protein 1 in colorectal cancer patients 大肠癌患者循环微小RNA-375和组织叶氏相关蛋白1的表达及其临床意义
Pub Date : 2020-01-08 DOI: 10.3760/CMA.J.ISSN.1001-9030.2020.01.042
Binzhong Zhang, Chun-yan He, Yinda Wang, Lairong Dong
Objective To explore the relationship between circle microRNA (miRNA, miR)-375 and tissue Yes-associated protein 1 (YAP1) expression in patients with colorectal cancer, as well as their relationship with clinicopathological characteristics of colorectal cancer. Methods Eighty-seven patients with colorectal cancer were selected as the study group, and 80 healthy volunteers served as the control group. The circle miR-375 expression in both groups was detected by quantitative polymerase chain reaction (PCR). The YAP1 expression in both cancer tissue and adjacent healthy tissue was detected by immunohistochemistry. The relationship between the two indexes and clinicopathological characteristics and prognosis was analyzed. The patients in the study group were divided into 3 groups according to miR-375 and YAP1 expression: Lower miR-375 and higher YAP1 (group A, n=21), both lower miR-375 and YAP1, or both higher miR-375 and YAP1 (group B, n=32), and higher miR-375 and lower YAP1 (group C, n=34). The relationship between the two indexes andprognosis was analyzed. Results The circle miR-375 expression in case group (0.132±0.085) was significantly lower than that in the control group (0.521±0.186), and the expression level of YAP1 in cancer tissues (2.201±0.856) was significantly higher than that in healthy tissues (0.814±0.262) (t=51.826, 51.175, P<0.05). There was a linear negative correlation between miR-375 and YAP1 expression (r=-0.691, P<0.05), and the interaction between them was confirmed in double luciferase assay report (t=9.564, P<0.05). The expression of both miR-375 and YAP1 was related to Dukes stage, and the miR-375 expression in patients with colorectal cancer of stage C was significantly lower than that in stage A and stage B, and the YAP1 expression in stage C was significantly higher than that in stage A and stage B (F=4.347, 3.724, P<0.05). The detection of miR-375 combined with YAP1 showed good predictive value for recurrence/metastasis and death of colorectal cancer (AUC=0.739, 0.699, P<0.05). The patients in group A got the shortest median survival time, while the patients in group C got the longest median survival time, and the difference between groups had statistical significance (χ2=4.685, P<0.05). Conclusion There is an interaction between mir-375 and YAP1, and both of them are involved in the occurrence and development of colorectal cancer. Key words: Colorectal cancer; MicroRNA-375; Yes-associated protein 1; Hippo signaling; Prognosis
目的探讨环微小RNA(miRNA,miR)-375与组织Yes-associated protein 1(YAP1)表达的关系及其与癌症临床病理特征的关系。方法选择87例癌症大肠癌患者为研究组,80名健康志愿者为对照组。通过定量聚合酶链式反应(PCR)检测两组中circle miR-375的表达。用免疫组织化学方法检测了YAP1在癌症组织和癌旁健康组织中的表达。分析两项指标与临床病理特征及预后的关系。根据miR-375和YAP1的表达,研究组中的患者被分为3组:较低的miR-375与较高的YAP1(A组,n=21),较低的iR-375与YAP1两者,或较高的miR-37与YAP1二者(B组,n=32),以及较高的miR-375与较低的YAP1两者(C组,n=34)。分析了两项指标与诊断的关系。结果病例组圆圈miR-375的表达(0.132±0.085)显著低于对照组(0.521±0.186),YAP1在癌症组织中的表达水平(2.201±0.856)显著高于健康组织(0.814±0.262)(t=51.826,51.175,P<0.05),二者之间的相互作用在双荧光素酶检测报告中得到证实(t=9.564,P<0.05)。miR-375和YAP1的表达均与Dukes分期有关,C期结直肠癌患者的miR-375表达显著低于A期和B期,C期YAP1表达显著高于A期和B期(F=4.347,3.724,P<0.05)。miR-375联合YAP1检测对癌症复发/转移和死亡具有良好的预测价值(AUC=0.739,0.699,P<0.01),C组患者中位生存时间最长,两组比较差异有统计学意义(x2=4.685,P<0.05)。关键词:结直肠癌癌症;MicroRNA-375;是相关蛋白1;Hippo信号;预后
{"title":"Expression and clinical significance of circulating microRNA-375 and tissue Yes-associated protein 1 in colorectal cancer patients","authors":"Binzhong Zhang, Chun-yan He, Yinda Wang, Lairong Dong","doi":"10.3760/CMA.J.ISSN.1001-9030.2020.01.042","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1001-9030.2020.01.042","url":null,"abstract":"Objective \u0000To explore the relationship between circle microRNA (miRNA, miR)-375 and tissue Yes-associated protein 1 (YAP1) expression in patients with colorectal cancer, as well as their relationship with clinicopathological characteristics of colorectal cancer. \u0000 \u0000 \u0000Methods \u0000Eighty-seven patients with colorectal cancer were selected as the study group, and 80 healthy volunteers served as the control group. The circle miR-375 expression in both groups was detected by quantitative polymerase chain reaction (PCR). The YAP1 expression in both cancer tissue and adjacent healthy tissue was detected by immunohistochemistry. The relationship between the two indexes and clinicopathological characteristics and prognosis was analyzed. The patients in the study group were divided into 3 groups according to miR-375 and YAP1 expression: Lower miR-375 and higher YAP1 (group A, n=21), both lower miR-375 and YAP1, or both higher miR-375 and YAP1 (group B, n=32), and higher miR-375 and lower YAP1 (group C, n=34). The relationship between the two indexes andprognosis was analyzed. \u0000 \u0000 \u0000Results \u0000The circle miR-375 expression in case group (0.132±0.085) was significantly lower than that in the control group (0.521±0.186), and the expression level of YAP1 in cancer tissues (2.201±0.856) was significantly higher than that in healthy tissues (0.814±0.262) (t=51.826, 51.175, P<0.05). There was a linear negative correlation between miR-375 and YAP1 expression (r=-0.691, P<0.05), and the interaction between them was confirmed in double luciferase assay report (t=9.564, P<0.05). The expression of both miR-375 and YAP1 was related to Dukes stage, and the miR-375 expression in patients with colorectal cancer of stage C was significantly lower than that in stage A and stage B, and the YAP1 expression in stage C was significantly higher than that in stage A and stage B (F=4.347, 3.724, P<0.05). The detection of miR-375 combined with YAP1 showed good predictive value for recurrence/metastasis and death of colorectal cancer (AUC=0.739, 0.699, P<0.05). The patients in group A got the shortest median survival time, while the patients in group C got the longest median survival time, and the difference between groups had statistical significance (χ2=4.685, P<0.05). \u0000 \u0000 \u0000Conclusion \u0000There is an interaction between mir-375 and YAP1, and both of them are involved in the occurrence and development of colorectal cancer. \u0000 \u0000 \u0000Key words: \u0000Colorectal cancer; MicroRNA-375; Yes-associated protein 1; Hippo signaling; Prognosis","PeriodicalId":10065,"journal":{"name":"中华实验外科杂志","volume":"37 1","pages":"144-147"},"PeriodicalIF":0.0,"publicationDate":"2020-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42013434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Construction of warning system for lung cancer by whole genome sequencing screening for sensitive methylation sites of non-small-cell lung carcinoma 非小细胞肺癌甲基化敏感位点全基因组序列筛查构建癌症预警系统
Pub Date : 2020-01-08 DOI: 10.3760/CMA.J.ISSN.1001-9030.2020.01.045
Jialiang Zhou, Haimin Wei, Jia Wu, Q. Fan, Dong-yan Cai
Objective To explore the construction of early warning system for non-small cell lung cancer (NSCLC) by whole genome sequencing. Methods The experiment was divided into two groups: normal tissue and NSCLC tissue. The expression of excision repair cross-complementation group 1 (ERCC1), tubb3 and RRM1 mRNA in NSCLC cells was detected by real-time quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR). The distribution of methylation in NSCLC cells was detected by whole genome sequencing. CpG methylation analysis was performed using sequencing data. Histone modification data were used to analyze the relationship between histone modification and DNA methylation. The expression of histone methylated eggs and methylated related enzymes in normal and NSCLC tissues were detected by protein immunoassay. Results Compared with the control cells, ERCC1 mRNA [(0.78±0.14) vs. (0.12±0.04), χ2=6.370, P<0.05] and RRM1 mRNA [(0.52±0.07) vs. (0.05±0.01), χ2=5.360, P<0.05] expression in NSCLC cells was down-regulated compared with control cells. Methylation level in NSCLC group increased at transcription start site and decreased in intergene region (χ2=3.140, P<0.05). Nine CpG methylation sensitive sites were found in the NSCLC group (RUNX3, MIR196A1, HOXA11, OTP, GATA4, PTPRU, SLC15A3, ZIC1 and TFAP2B). NSCLC group compared with control group, the lower histone acetylation [(H3K9ac [(43.57±8.84) vs. (10.64±4.35), χ2=8.730, P<0.05] and H3K27ac [(40.52±8.64) vs. (9.67±3.58), χ2=5.470, P<0.05) ] and histone methylation [(H2az [(42.56±9.74) vs. (12.47±6.05), χ2=7.420, P<0.05]. H3K4me1 [(37.47±6.42) vs. (15.46±7.34), χ2=5.380, P<0.05], H3K4me2 [(50.37±10.24) vs. (9.47±6.54), χ2=9.270, P<0.05]. H3K4me3 [(52.37±6.49) vs. (10.58±5.88), χ2=1.690, P<0.05] and H3K79me2 [(34.55±6.42) vs. (11.23±6.94), χ2=3.450, P<0.05]. Compared to the control group, NSCLC group DNMT1 express cut [(1.88±0.24) vs. (0.12±0.01), χ2=5.430, P<0.05], DNMT3a expression cut [(1.75±0.36) vs. (0.49±0.11), χ2=7.890, P<0.05], expression of DNMT3b cut [(0.88±0.14) vs. (0.13±0.05), χ2=1.360, P<0.05], expression of H3K4me3 cut [(2.53±0.35) vs. (0.35±0.08), χ2=5.440, P<0.05), H3K9me2 expression cut (0.55±0.07) vs. (0.05±0.01), χ2=3.270, P<0.05]. Conclusion Histone modification is closely related to DNA methylation, and the expression of histone methylation and methylation-related enzymes is also affected. Methylation sensitive sites can be used as biomarkers for early detection of NSCLC. Key words: Whole genome sequencing; Non-small-cell lung carcinoma; Methylation; Histone modification; Lung cancer cells
目的探讨癌症(NSCLC)全基因组测序预警系统的构建。方法实验分为正常组织和非小细胞肺癌组织两组。实时定量逆转录聚合酶链反应(RT-qPCR)检测切除修复交叉互补组1(ERCC1)、tubb3和RRM1 mRNA在NSCLC细胞中的表达。通过全基因组测序检测甲基化在NSCLC细胞中的分布。使用测序数据进行CpG甲基化分析。组蛋白修饰数据用于分析组蛋白修饰与DNA甲基化之间的关系。用蛋白质免疫分析法检测组蛋白甲基化蛋和甲基化相关酶在正常和NSCLC组织中的表达。结果与对照细胞相比,NSCLC细胞ERCC1 mRNA[(0.78±0.14)vs(0.12±0.04),χ2=6.370,P<0.05]和RRM1 mRNA[(0.52±0.07)vs.(0.05±0.01),χ0=5.360,P<0.05]的表达较对照细胞下调。NSCLC组的甲基化水平在转录起始位点升高,在基因间区域降低(χ2=3.140,P<0.05)。NSCLC组发现9个CpG甲基化敏感位点(RUNX3、MIR196A1、HOXA11、OTP、GATA4、PTPRU、SLC15A3、ZIC1和TFAP2B)。NSCLC组与对照组相比,组蛋白乙酰化[(H3K9ac[(43.57±8.84)vs.(10.64±4.35),χ2=8.730,P<0.05]和H3K27ac[(40.52±8.64)vs..(9.67±3.58),χ0=5.470,P<0.05)]和组蛋白甲基化[(H2az[(42.56±9.74)vs.:(12.47±6.05),σ2=7.420,P<0.05]较低,H3K4me2[(50.37±10.24)vs.(9.47±6.54),χ2=9.270,P<0.05]。±0.36)vs.(0.49±0.11),χ2=7.890,P<0.05,DNMT3b片段的表达[(0.88±0.14)vs.(0.13±0.05),χ2=1.360,P<0.05],H3K4me3片段的表达(2.53±0.35)vs。甲基化敏感位点可作为NSCLC早期检测的生物标志物。关键词:全基因组测序;非小细胞肺癌;甲基化;组蛋白修饰;癌症肺癌细胞
{"title":"Construction of warning system for lung cancer by whole genome sequencing screening for sensitive methylation sites of non-small-cell lung carcinoma","authors":"Jialiang Zhou, Haimin Wei, Jia Wu, Q. Fan, Dong-yan Cai","doi":"10.3760/CMA.J.ISSN.1001-9030.2020.01.045","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1001-9030.2020.01.045","url":null,"abstract":"Objective \u0000To explore the construction of early warning system for non-small cell lung cancer (NSCLC) by whole genome sequencing. \u0000 \u0000 \u0000Methods \u0000The experiment was divided into two groups: normal tissue and NSCLC tissue. The expression of excision repair cross-complementation group 1 (ERCC1), tubb3 and RRM1 mRNA in NSCLC cells was detected by real-time quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR). The distribution of methylation in NSCLC cells was detected by whole genome sequencing. CpG methylation analysis was performed using sequencing data. Histone modification data were used to analyze the relationship between histone modification and DNA methylation. The expression of histone methylated eggs and methylated related enzymes in normal and NSCLC tissues were detected by protein immunoassay. \u0000 \u0000 \u0000Results \u0000Compared with the control cells, ERCC1 mRNA [(0.78±0.14) vs. (0.12±0.04), χ2=6.370, P<0.05] and RRM1 mRNA [(0.52±0.07) vs. (0.05±0.01), χ2=5.360, P<0.05] expression in NSCLC cells was down-regulated compared with control cells. Methylation level in NSCLC group increased at transcription start site and decreased in intergene region (χ2=3.140, P<0.05). Nine CpG methylation sensitive sites were found in the NSCLC group (RUNX3, MIR196A1, HOXA11, OTP, GATA4, PTPRU, SLC15A3, ZIC1 and TFAP2B). NSCLC group compared with control group, the lower histone acetylation [(H3K9ac [(43.57±8.84) vs. (10.64±4.35), χ2=8.730, P<0.05] and H3K27ac [(40.52±8.64) vs. (9.67±3.58), χ2=5.470, P<0.05) ] and histone methylation [(H2az [(42.56±9.74) vs. (12.47±6.05), χ2=7.420, P<0.05]. H3K4me1 [(37.47±6.42) vs. (15.46±7.34), χ2=5.380, P<0.05], H3K4me2 [(50.37±10.24) vs. (9.47±6.54), χ2=9.270, P<0.05]. H3K4me3 [(52.37±6.49) vs. (10.58±5.88), χ2=1.690, P<0.05] and H3K79me2 [(34.55±6.42) vs. (11.23±6.94), χ2=3.450, P<0.05]. Compared to the control group, NSCLC group DNMT1 express cut [(1.88±0.24) vs. (0.12±0.01), χ2=5.430, P<0.05], DNMT3a expression cut [(1.75±0.36) vs. (0.49±0.11), χ2=7.890, P<0.05], expression of DNMT3b cut [(0.88±0.14) vs. (0.13±0.05), χ2=1.360, P<0.05], expression of H3K4me3 cut [(2.53±0.35) vs. (0.35±0.08), χ2=5.440, P<0.05), H3K9me2 expression cut (0.55±0.07) vs. (0.05±0.01), χ2=3.270, P<0.05]. \u0000 \u0000 \u0000Conclusion \u0000Histone modification is closely related to DNA methylation, and the expression of histone methylation and methylation-related enzymes is also affected. Methylation sensitive sites can be used as biomarkers for early detection of NSCLC. \u0000 \u0000 \u0000Key words: \u0000Whole genome sequencing; Non-small-cell lung carcinoma; Methylation; Histone modification; Lung cancer cells","PeriodicalId":10065,"journal":{"name":"中华实验外科杂志","volume":"37 1","pages":"155-157"},"PeriodicalIF":0.0,"publicationDate":"2020-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44777653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long non-coding RNA HIT promotes bladder cancer proliferation and invasion by regulating epithelial-mesenchymal transition 长链非编码RNA HIT通过调节上皮-间质转化促进膀胱癌的增殖和侵袭
Pub Date : 2020-01-08 DOI: 10.3760/CMA.J.ISSN.1001-9030.2020.01.053
F. Wan, K. Feng, X. Qu, Y. Xia, Haibin Guo, Cuilian Zhang
{"title":"Long non-coding RNA HIT promotes bladder cancer proliferation and invasion by regulating epithelial-mesenchymal transition","authors":"F. Wan, K. Feng, X. Qu, Y. Xia, Haibin Guo, Cuilian Zhang","doi":"10.3760/CMA.J.ISSN.1001-9030.2020.01.053","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1001-9030.2020.01.053","url":null,"abstract":"","PeriodicalId":10065,"journal":{"name":"中华实验外科杂志","volume":"37 1","pages":"178-179"},"PeriodicalIF":0.0,"publicationDate":"2020-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45618110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress in relationship between microRNAs and alcoholic liver disease 微小RNA与酒精性肝病关系的研究进展
Pub Date : 2020-01-08 DOI: 10.3760/CMA.J.ISSN.1001-9030.2020.01.060
Zhan Wu, Fudi Zhong, Guandou Yuan, Songqing He
Alcoholic liver disease (ALD) is a major health problem globally. Long-term drinking can lead to fatty liver and inflammation, which in turn may cause liver fibrosis, cirrhosis or liver cancer. At present, the potential mechanism is not fully understood, and growing evidence shows that microRNAs (miRNAs, miR) play an important role in different stages of ALD. In this paper, the research progress in the role of various miRNAs in different stages of ALD is reviewed, and their application in ALD is prospected. Key words: Alcoholic liver disease; MicroRNA; Alcoholic fatty liver; Alcoholic hepatitis; Alcohol hepatic fibrosis
酒精性肝病(ALD)是全球范围内的一个主要健康问题。长期饮酒会导致脂肪肝和炎症,进而可能导致肝纤维化、肝硬化或肝癌。目前,其潜在机制尚不完全清楚,越来越多的证据表明,微小RNA(miRNA,miR)在ALD的不同阶段发挥着重要作用。本文综述了各种miRNA在ALD不同阶段作用的研究进展,并对其在ALD中的应用进行了展望。关键词:酒精性肝病;微小核糖核酸;酒精性脂肪肝;酒精性肝炎;酒精性肝纤维化
{"title":"Research progress in relationship between microRNAs and alcoholic liver disease","authors":"Zhan Wu, Fudi Zhong, Guandou Yuan, Songqing He","doi":"10.3760/CMA.J.ISSN.1001-9030.2020.01.060","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1001-9030.2020.01.060","url":null,"abstract":"Alcoholic liver disease (ALD) is a major health problem globally. Long-term drinking can lead to fatty liver and inflammation, which in turn may cause liver fibrosis, cirrhosis or liver cancer. At present, the potential mechanism is not fully understood, and growing evidence shows that microRNAs (miRNAs, miR) play an important role in different stages of ALD. In this paper, the research progress in the role of various miRNAs in different stages of ALD is reviewed, and their application in ALD is prospected. \u0000 \u0000Key words: \u0000Alcoholic liver disease; MicroRNA; Alcoholic fatty liver; Alcoholic hepatitis; Alcohol hepatic fibrosis","PeriodicalId":10065,"journal":{"name":"中华实验外科杂志","volume":"37 1","pages":"194-198"},"PeriodicalIF":0.0,"publicationDate":"2020-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42335360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on the mechanism of long non-coding RNA migration inhibitory factor antisense RNA1 in regulating proliferation, invasion and metastasis of non-small cell lung cancer 长非编码RNA迁移抑制因子反义RNA1调节癌症增殖、侵袭和转移机制的研究
Pub Date : 2020-01-08 DOI: 10.3760/CMA.J.ISSN.1001-9030.2020.01.022
Jiwei Li, Quan Zhang, Lei Xu, Zibo Zhu, Saisai Li, Li Wei
Objective To explore the molecular mechanism by which long non-coding RNA (lncRNA) migration inhibitory factor antisense RNA1 (MIF-AS1)/microRNA (miRNAM miR)-370-3p/mitogen activated protein kinase 9 (MAP3K9) molecular axis regulates proliferation, invasion and migration of non-small cell lung cancer (NSCLC). Methods Twenty cancer samples of NSCLC patients were collected from Henan Provincial People’s Hospital from May 2017 to January 2019. There were 12 males and 8 females, aged (52.37±10.34) years. Real-time quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR) and Western blotting were used to detect the expression levels of MIF-AS1, miR-370-3p and MAP3K9 in cancer tissues and 9 cell lines. NSCLC A549 cells were transfected with si-MIF-AS1, si-NC, si-MIF-AS1+ anti-miR-370-3p or si-MIF-AS1+ pcDNA-MAP3K9, respectively. Methyl thiazol tetrazolium (MTT) assay and Transwell assay were used to detect the proliferation, migration and invasion of transfected cells. Western blotting was used to detect the expression of Cyclin D1, p21, p27, matrix metalloproteinase (MMP)-2, MMP-9 and MMP-14 proteins. The dual luciferase reporter gene verified the targeting regulation of MIF-AS1 on miR-370-3p and miR-370-3p on MAP3K9. Results The expression of MIF-AS1 and MAP3K9 in NSCLC tissues (2.49±0.25 and 2.24±0.22) and A549 cells (2.54±0.24 and 2.31±0.23), H1299 cells (2.11±0.21 and 2.44±0.24) and PC-9 cells (2.26±0.23 and 2.16±0.22) was significantly higher than that in adjacent tissues (1.00±0.09 and 1.02±0.09) and normal lung epithelial cells BEAS-2B (1.01±0.09 and 1.00±0.09) (t=25.078, P<0.05; F=94.367, P<0.05). The expression of miR-370-3p in NSCLC tissues (0.42±0.04), A549 cells (0.34±0.03), H1299 cells (0.53±0.05), and PC-9 cells (0.44±0.04) was significantly lower than that in adjacent tissues (1.01±0.08) and BEAS-2B cells (1.00±0.08) (t=29.500, P<0.05; F=269.552, P<0.05). Transfection with si-MIF-AS1 significantly inhibited NSCLC cell proliferation (24 h: 0.27±0.03, 48 h: 0.36±0.03, 72 h: 0.48±0.04), invasion (24.33±3.14), migration (32.46±3.34) ability (P<0.01), up-regulated p21 (0.64±0.06), p27 (0.77±0.07) protein expression (t=17.441, P<0.05; t=17.726, P<0.05) and down-regulated Cyclin D1 (0.29±0.03), MMP-2 (0.25±0.03), MMP-9 (0.34±0.03) and MMP-14 (0.29±0.03) protein expression (t=17.732, P<0.05). The dual luciferase reporter gene confirmed that MIF-AS1 was bond to miR-370-3p and miR-370-3p was bond to MAP3K9. Transfection with si-MIF-AS1+ anti-miR-370-3p or si-MIF-AS1+ pcDNA-MAP3K9 inhibited the effects of si-MIF-AS1 on proliferation, invasion and migration of NSCLC cells. Conclusion LncRNA MIF-AS1 promotes proliferation, migration and invasion of NSCLCs by regulating miR-370-3p/MAP3K9 molecular axis. Key words: Non-small cell lung cancer; Long non-coding RNA migration inhibitory factor antisense RNA1; MicroRNA-370-3p; Mitogen activated protein kinase 9; Proliferation; Migration; Invasion
目的探讨长非编码RNA(lncRNA)迁移抑制因子反义RNA1(MIF-AS1)/microRNA(miRNAM-miR)-370-3p/丝裂原活化蛋白激酶9(MAP3K9)分子轴调控癌症(NSCLC)增殖、侵袭和迁移的分子机制。方法收集河南省人民医院2017年5月至2019年1月收治的20例癌症NSCLC患者样本。男12例,女8例,年龄(52.37±10.34)岁。采用实时定量逆转录聚合酶链反应(RT-qPCR)和蛋白质印迹法检测了MIF-AS1、miR-370-3p和MAP3K9在癌症组织和9种细胞系中的表达水平。分别用si-MIF-AS1、si-NC、si-MIF-AS1+抗miR-370-3p或si-MIF-A S1+pcDNA-MAP3K9转染NSCLC A549细胞。采用MTT法和Transwell法检测转染细胞的增殖、迁移和侵袭。蛋白质印迹法检测细胞周期蛋白D1、p21、p27、基质金属蛋白酶(MMP)-2、MMP-9和MMP-14的表达。双荧光素酶报告基因验证了MIF-AS1对miR-370-3p和miR-370-3p对MAP3K9的靶向调节。结果MIF-AS1和MAP3K9在NSCLC组织(2.49±0.25和2.24±0.22)和A549细胞(2.54±0.24和2.31±0.23)中的表达,H1299细胞(2.11±0.21和2.44±0.24)和PC-9细胞(2.26±0.23和2.16±0.22,PC-9细胞(0.44±0.04)显著低于邻近组织(1.01±0.08)和BEAS-2B细胞(1.00±0.08)(t=29.500,P<0.05;F=269.52,P<0.05),p27(0.77±0.07)蛋白表达(t=17.441,P<0.05;t=17.726,P<0.05),下调Cyclin D1(0.29±0.03)、MMP-2(0.25±0.03),MMP-9(0.34±0.03)和MMP-14(0.29士0.03)蛋白表达,t=17.732,P<0.05)。用si-MIF-AS1+抗miR-370-3p或si-MIF-AS1+pcDNA-MAP3K9转染抑制了si-MIF-A S1对NSCLC细胞增殖、侵袭和迁移的影响。结论LncRNA-MIF-AS1通过调节miR-370-3p/MAP3K9分子轴,促进NSCLC的增殖、迁移和侵袭。关键词:非小细胞肺癌;长非编码RNA迁移抑制因子反义RNA1;MicroRNA-370-3p;丝裂原活化蛋白激酶9;扩散;移民;入侵
{"title":"Study on the mechanism of long non-coding RNA migration inhibitory factor antisense RNA1 in regulating proliferation, invasion and metastasis of non-small cell lung cancer","authors":"Jiwei Li, Quan Zhang, Lei Xu, Zibo Zhu, Saisai Li, Li Wei","doi":"10.3760/CMA.J.ISSN.1001-9030.2020.01.022","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1001-9030.2020.01.022","url":null,"abstract":"Objective \u0000To explore the molecular mechanism by which long non-coding RNA (lncRNA) migration inhibitory factor antisense RNA1 (MIF-AS1)/microRNA (miRNAM miR)-370-3p/mitogen activated protein kinase 9 (MAP3K9) molecular axis regulates proliferation, invasion and migration of non-small cell lung cancer (NSCLC). \u0000 \u0000 \u0000Methods \u0000Twenty cancer samples of NSCLC patients were collected from Henan Provincial People’s Hospital from May 2017 to January 2019. There were 12 males and 8 females, aged (52.37±10.34) years. Real-time quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR) and Western blotting were used to detect the expression levels of MIF-AS1, miR-370-3p and MAP3K9 in cancer tissues and 9 cell lines. NSCLC A549 cells were transfected with si-MIF-AS1, si-NC, si-MIF-AS1+ anti-miR-370-3p or si-MIF-AS1+ pcDNA-MAP3K9, respectively. Methyl thiazol tetrazolium (MTT) assay and Transwell assay were used to detect the proliferation, migration and invasion of transfected cells. Western blotting was used to detect the expression of Cyclin D1, p21, p27, matrix metalloproteinase (MMP)-2, MMP-9 and MMP-14 proteins. The dual luciferase reporter gene verified the targeting regulation of MIF-AS1 on miR-370-3p and miR-370-3p on MAP3K9. \u0000 \u0000 \u0000Results \u0000The expression of MIF-AS1 and MAP3K9 in NSCLC tissues (2.49±0.25 and 2.24±0.22) and A549 cells (2.54±0.24 and 2.31±0.23), H1299 cells (2.11±0.21 and 2.44±0.24) and PC-9 cells (2.26±0.23 and 2.16±0.22) was significantly higher than that in adjacent tissues (1.00±0.09 and 1.02±0.09) and normal lung epithelial cells BEAS-2B (1.01±0.09 and 1.00±0.09) (t=25.078, P<0.05; F=94.367, P<0.05). The expression of miR-370-3p in NSCLC tissues (0.42±0.04), A549 cells (0.34±0.03), H1299 cells (0.53±0.05), and PC-9 cells (0.44±0.04) was significantly lower than that in adjacent tissues (1.01±0.08) and BEAS-2B cells (1.00±0.08) (t=29.500, P<0.05; F=269.552, P<0.05). Transfection with si-MIF-AS1 significantly inhibited NSCLC cell proliferation (24 h: 0.27±0.03, 48 h: 0.36±0.03, 72 h: 0.48±0.04), invasion (24.33±3.14), migration (32.46±3.34) ability (P<0.01), up-regulated p21 (0.64±0.06), p27 (0.77±0.07) protein expression (t=17.441, P<0.05; t=17.726, P<0.05) and down-regulated Cyclin D1 (0.29±0.03), MMP-2 (0.25±0.03), MMP-9 (0.34±0.03) and MMP-14 (0.29±0.03) protein expression (t=17.732, P<0.05). The dual luciferase reporter gene confirmed that MIF-AS1 was bond to miR-370-3p and miR-370-3p was bond to MAP3K9. Transfection with si-MIF-AS1+ anti-miR-370-3p or si-MIF-AS1+ pcDNA-MAP3K9 inhibited the effects of si-MIF-AS1 on proliferation, invasion and migration of NSCLC cells. \u0000 \u0000 \u0000Conclusion \u0000LncRNA MIF-AS1 promotes proliferation, migration and invasion of NSCLCs by regulating miR-370-3p/MAP3K9 molecular axis. \u0000 \u0000 \u0000Key words: \u0000Non-small cell lung cancer; Long non-coding RNA migration inhibitory factor antisense RNA1; MicroRNA-370-3p; Mitogen activated protein kinase 9; Proliferation; Migration; Invasion","PeriodicalId":10065,"journal":{"name":"中华实验外科杂志","volume":"37 1","pages":"75-80"},"PeriodicalIF":0.0,"publicationDate":"2020-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43197891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华实验外科杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1